DCP
DSM Capital Partners’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-326
| Closed | -$22.1K | – | 103 |
|
|
2024
Q1 | $22.1K | Buy |
326
+103
| +46% | +$6.98K | ﹤0.01% | 99 |
|
|
2023
Q4 | $15K | Sell |
223
-39,708
| -99% | -$2.67M | ﹤0.01% | 115 |
|
|
2023
Q3 | $2.7M | Sell |
39,931
-1,729,220
| -98% | -$117M | 0.05% | 35 |
|
|
2023
Q2 | $127M | Sell |
1,769,151
-319,550
| -15% | -$22.9M | 2.05% | 19 |
|
|
2023
Q1 | $145M | Sell |
2,088,701
-140,386
| -6% | -$9.74M | 2.37% | 17 |
|
|
2022
Q4 | $151M | Sell |
2,229,087
-54,088
| -2% | -$3.67M | 2.51% | 15 |
|
|
2022
Q3 | $125M | Sell |
2,283,175
-12,060
| -0.5% | -$661K | 2.12% | 19 |
|
|
2022
Q2 | $152M | Buy |
2,295,235
+1,756,218
| +326% | +$116M | 2.54% | 13 |
|
|
2022
Q1 | $35.8M | Buy |
539,017
+36,622
| +7% | +$2.43M | 0.48% | 28 |
|
|
2021
Q4 | $29.3M | Buy |
502,395
+87,775
| +21% | +$5.11M | 0.31% | 29 |
|
|
2021
Q3 | $24.9M | Buy |
414,620
+48,834
| +13% | +$2.93M | 0.26% | 28 |
|
|
2021
Q2 | $21.9M | Sell |
365,786
-68,552
| -16% | -$4.11M | 0.21% | 28 |
|
|
2021
Q1 | $21.6M | Buy |
434,338
+36,412
| +9% | +$1.81M | 0.23% | 29 |
|
|
2020
Q4 | $19.9M | Buy |
397,926
+324,766
| +444% | +$16.2M | 0.21% | 28 |
|
|
2020
Q3 | $4.01M | Buy |
73,160
+250
| +0.3% | +$13.7K | 0.04% | 33 |
|
|
2020
Q2 | $3.86M | Buy |
+72,910
| New | +$3.86M | 0.05% | 34 |
|